Table 2.

Psychiatric Medications at Time of Referral.

Medication Characteristics at Time of Referral	Active Medications	Previous Medications
Total patients (n)	166
%Any SSRI, SNRI, or Clomipramine	84.9	57.8
%SSRI	75.9	57.2
%SNRI	6.6	10.2
%Clomipramine	4.2	1.8
%Other Antidepressants	13.3	9.0
%Bupropion	6.6	5.4
%Trazodone	3.6	1.2
%Mirtazapine	3.0	2.4
%SGAs	37.3	21.1
%Risperidone	10.2	5.4
%Aripiprazole	9.0	13.9
%Quetiapine	8.4	3.6
%Olanzapine	5.4	3.0
%Lurasidone	5.4	3.0
%Cariprazine or Ziprasidone	1.8	0
%Other OCD Augmenting Agents	4.8	0.6
%N-Acetylcysteine	4.2	0.6
%Memantine	1.2	0
%Benzodiazepines	9.0	3.6
%Other Anxiolytics or Sleep Aids	23.5	12.0
%Hydroxyzine	9.6	7.2
%Melatonin	6.0	0
%Propranolol	5.4	0.6
%Clonidine	4.2	1.8
%Buspirone	3.0	1.8
%ADHD Medications	22.3	19.3
%Stimulant	16.9	17.5
%Guanfacine or Atomoxetine	6.6	4.2
%Mood Stabilizers a	10.2	2.4
Non-Psychiatric Medications or Supplements	32.5	—
%Supplements	13.9	—
%Oral Contraceptives	6.0	—
%NSAIDs	4.2	—
%Oral Antibiotics	3.6	—
%Metformin	2.4	—
%Oral Immunosuppressants and Steroids	1.2	—

^a Lamotrigine, lithium, valproic acid, gabapentin, or topiramate.